0.749
前日終値:
$0.7183
開ける:
$0.7183
24時間の取引高:
696.81K
Relative Volume:
1.31
時価総額:
$61.95M
収益:
$38.70M
当期純損益:
$-117.88M
株価収益率:
-0.4406
EPS:
-1.7
ネットキャッシュフロー:
$-92.84M
1週間 パフォーマンス:
+7.11%
1か月 パフォーマンス:
+10.88%
6か月 パフォーマンス:
-33.67%
1年 パフォーマンス:
-48.77%
Adicet Bio Inc Stock (ACET) Company Profile
ACET を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ACET
Adicet Bio Inc
|
0.749 | 57.89M | 38.70M | -117.88M | -92.84M | -1.70 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-09-30 | 再開されました | Guggenheim | Buy |
2024-09-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2023-06-27 | ダウングレード | Guggenheim | Buy → Neutral |
2023-06-27 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2023-06-01 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-09-21 | 開始されました | JP Morgan | Overweight |
2022-03-31 | 開始されました | SMBC Nikko | Outperform |
2022-03-08 | 開始されました | Truist | Buy |
2022-03-04 | 開始されました | Jefferies | Buy |
2021-05-18 | 開始されました | BTIG Research | Buy |
2021-04-23 | 開始されました | H.C. Wainwright | Buy |
2021-04-14 | 開始されました | Canaccord Genuity | Buy |
2021-04-08 | 開始されました | Guggenheim | Buy |
2020-11-04 | 開始されました | B. Riley Securities | Buy |
2020-10-27 | 開始されました | JMP Securities | Mkt Outperform |
2020-10-16 | 開始されました | Wedbush | Outperform |
すべてを表示
Adicet Bio Inc (ACET) 最新ニュース
Adicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal year - Investing.com
Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference - Business Wire
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50 - Defense World
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - MSN
Adicet Bio (NASDAQ:ACET) Coverage Initiated at StockNews.com - Defense World
Wedbush Comments on Adicet Bio’s Q3 Earnings (NASDAQ:ACET) - Defense World
What is Wedbush’s Estimate for Adicet Bio Q1 Earnings? - Defense World
Adicet Bio Reports Q1 2025 Results and Updates - TipRanks
Marshall Wace LLP Sells 104,894 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph
ACET's Cash Reserves Expected to Sustain Operations Until Late 2 - GuruFocus
Adicet Bio, Inc. (NASDAQ:ACET) Shares Acquired by JPMorgan Chase & Co. - Defense World
Reviewing Adicet Bio (NASDAQ:ACET) and HUTCHMED (NASDAQ:HCM) - Defense World
Renaissance Technologies LLC Has $882,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Yahoo Finance
Adicet Bio (NASDAQ:ACET) Rating Increased to Hold at StockNews.com - Defense World
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - BioSpace
Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting - marketscreener.com
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate - Yahoo Finance
JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com Canada
JMP maintains Market Perform on Adicet Bio shares - Investing.com
Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World
Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada
Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace
Adicet Bio appoints Michael Grissinger to its board - Investing.com
Adicet Bio Appoints Michael Grissinger to Board - TipRanks
Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com
Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan
Neuroscientific to Acquire Leading Stem Cell Technology - Investing News Network
Norges Bank Acquires Shares of 429,550 Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Adicet Bio faces potential Nasdaq delisting over share price - Investing.com
Virtu Financial LLC Purchases New Stake in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio Inc (ACET) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):